Clascoterone for Hair Loss: How the New Active Ingredient Could Revolutionize Treatment

Treatment for hereditary hair loss (androgenetic alopecia) may be on the verge of a historic turning point. After decades without any fundamentally new drug approvals in this area, pharmaceutical company Cosmo Pharmaceuticals published the highly anticipated phase III results for its active ingredient Clascoterone on April 15, 2026. The data suggest that we may soon see the first topical antiandrogen on the market that acts directly at the hair root and can significantly slow the progression of hair loss.

What is Clascoterone and how does it work?

Clascoterone (also known by its development name, Breezula) is a topical androgen receptor antagonist. Unlike systemic medications such as finasteride, which affect hormone levels throughout the body, Clascoterone is applied locally to the scalp as a 5% solution. There, it blocks androgen receptors in the hair follicles, preventing the hair-loss-causing hormone dihydrotestosterone (DHT) from binding to them. This neutralizes DHT’s harmful effects on the hair roots without lowering systemic testosterone levels.

Studies have shown that Clascoterone reduces the secretion of the pro-inflammatory, hair-growth-inhibiting cytokine interleukin-6 (IL-6) in bald areas of the scalp. At the same time, it promotes dermal papilla inductivity and hair matrix keratinocyte proliferation to a similar extent as established active ingredients, resulting in visibly thicker hair.

The groundbreaking phase III results of 2026

The recently published data are based on the largest Phase III clinical trial program ever conducted for a topical treatment for androgenetic alopecia in men. A total of 1,465 patients took part in the SCALP 1 and SCALP 2 studies at 51 centers in the US and Europe. The 12-month results are extremely promising.

Patients who used clascoterone for the full 12 months saw a statistically significant 2.39-fold improvement in hair density (Target Area Hair Count) compared with those who switched to a placebo after six months. In addition, users reported 24.5 percent greater satisfaction with the treatment. The company now plans to apply for approval from the US Food and Drug Administration and the European Medicines Agency in early 2027. If approved, clascoterone would be the first new hair loss medication since finasteride was approved in 1997.

Holistic Care: How You Can Support the Effects

While we wait for new active medical ingredients to be approved, it is crucial to support the scalp and hair follicles as effectively as possible. A healthy microbiome and an optimal supply of nutrients form the foundation for successful hair growth. A combination of internal and external care has proven particularly effective.

You can strengthen your hair roots from within with targeted nutrients. KÖ-HAIR Hair Loading Capsules offer an optimally balanced blend of vitamins, trace elements, and plant extracts that act as natural DHT blockers and support hair growth.

Hair Loading Capsules supply the hair roots with essential nutrients from within.

Local Scalp Stimulation

For external use, experts recommend circulation-boosting and cell-stimulating serums. The KÖ-HAIR Circulation Serum Spray uses the patented active ingredient Redensyl® to reactivate hair follicle stem cells. Like future topical treatments, it is applied directly to affected areas, where it specifically promotes microcirculation and cell growth.

Circulation Serum Spray revitalizes the scalp and promotes natural hair growth.

Laying the Right Foundation

Any topical treatment—whether current serums or future medications—can only work optimally if the scalp is clean and ready to absorb it. A deep-cleansing yet gentle shampoo is therefore essential. The KÖ-HAIR Circulation Shampoo clears pores of sebum and residue, ideally preparing the scalp for subsequent care. For users who have already had a hair transplant or are preparing for one, the KÖ-HAIR Care Line offers a gentle and effective solution for maintaining scalp health over the long term.

Circulation Shampoo optimally prepares the scalp to absorb active ingredients.

Conclusion: A Promising Future

The positive results of the clascoterone studies are giving millions of men worldwide new hope in the fight against hereditary hair loss. A locally acting androgen receptor blocker could revolutionize treatment options and offer an effective alternative or complement to existing therapies. Until its anticipated launch, the best strategy for keeping your hair for as long and as healthy as possible is a combination of a nutrient-rich diet, circulation-boosting serums, and optimal scalp hygiene.